This internal promotion strengthens the business unit and enhances the Executive Committee (COMEX).
Two successful FDA inspections assure customers of Novasep’s strict compliance with US pharmaceutical processing standards.
CFO appointment is a key milestone in Novasep’s senior management recruitment program.
Pompey, France, 26 June 2013 - Novasep, a leading provider of purificationbased manufacturing solutions for life sciences molecules, today announces the appointment of Michel Spagnol as President and CEO of the company, effective from 25 June 2013. He will succeed Patrick Glaser, who after three years at Novasep in France, has decided to return to the USA. Michel Spagnol joins Novasep from Shasun, where he was President and Chief Technology Officer. He is a proven business leader with core expertise in leading contract manufacturing of active pharmaceutical ingredients and, more broadly, strong experience in using and developing innovative technologies to address needs of customers in fine chemicals and life sciences fields. Prior to Shasun Michel Spagnol spent his career at Rhodia in Lyon and Cranbury (NJ, USA) where he progressed first in technical R&D leadership roles and subsequently transitioned to business development as a Sales and Marketing Vice President of Rhodia Pharma Solutions.
Pompey, France and Leverkusen, Germany, June 4, 2013 - Novasep, a leading supplier of manufacturing solutions to the life sciences industry, announces it has strengthened its position in the fine chemicals marketplace with the appointment of Udo Steinhauer as fine chemicals market director within the synthesis business unit of Novasep.
Novasep reclassifies reagent and informs market about new safety measures required.
State of the Art Processes in Large Scale Production of Pharmaceuticals and Fine Chemicals.
Sius(TM) TFF skid to be showcased at the Disposable Solutions for Biomanufacturing tradeshow in Brussels on February 19-20, 2013.
New plant on its Mourenx, France site to produce a large volume commercial API.
Pompey, France, 2nd October 2012 - Novasep, a leading provider of purification-based manufacturing solutions for life science molecules, today announces the appointment of Roger-Marc Nicoud, founder and CEO, as Non-Executive Chairman of the Board, effective on October 1st, 2012.